Planning Grant: I/UCRC for technology innovation for novel cost-reducing and quality-enhancing musculoskeletal therapies

规划补助金：I/UCRC 用于新型降低成本和提高质量的肌肉骨骼疗法的技术创新

• 批准号: 1265896
• 负责人: Jeffrey Lotz
• 金额: $ 3.84万
• 依托单位: University of California-San Francisco
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-01-01 至 2014-05-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1265896&HistoricalAwards=false
• 关键词: Planning; Grant; UCRC; technology; innovation

1265896 University of California-San Francisco (UCSF); Jeffrey Lotz The proposed center will focus on technological advances and trends of health outcomes, quality, and costs associated with several areas of musculoskeletal care, including spine, arthroplasty, and sports medicine. University of California, San Francisco (UCSF), the University of Toledo (UT), and the University of California-Berkeley (UCB) are collaborating to establish the proposed center, with UCSF as the lead institution. With current trends in healthcare reform, there is a growing conflict between the need for medical cost containment and the nation's commitment to technological innovation to improve human health. Consequently, successful medical therapy development now includes not only advancing new technologies that are safe and effective, but also factoring overall costs for the episode of care, pricing, and reimbursement. Disruptive innovations are new technologies that are cost-saving, or that add value to the healthcare encounter by improving outcome and/or reducing cost. Success in developing disruptive musculoskeletal innovations requires balancing clinical insight, technological know-how, supply chain management, and commercial market intelligence. The proposed activity involves substantial engineering and bio-engineering multi-disciplinary collaboration. Business faculty involvement provides a solid approach to the engineering systems challenge of maximizing the value of innovative therapies. The proposed Center will represent an exciting and novel integration of healthcare economics, biomedical science, and clinical medicine as we target technological innovations on cost-cutting and quality-enhancing interventions for management of patients with musculoskeletal disease. The proposed Center will focus on a natural integration of multi-disciplinary research activities, and consequently, a cross-fertilization that provides rich educational experiences for trainees who are mentored during the supported research activities. The Center plans to implement an active program for identifying and including Center members and trainees from underrepresented groups. Important data and findings will be disseminated and shared via the Center website and publications that result from Center-supported research.

1265896加州大学旧金山分校弗朗西斯科（UCSF）;杰弗里·洛茨拟议中的中心将专注于技术进步和健康结果的趋势，质量和成本与肌肉骨骼护理的几个领域，包括脊柱，关节成形术和运动医学。加州大学旧金山弗朗西斯科（UCSF）、托莱多大学（UT）和加州大学伯克利分校（UCB）正在合作建立拟议中的中心，UCSF是牵头机构。随着当前医疗保健改革的趋势，医疗成本控制的需求与国家致力于技术创新以改善人类健康之间的冲突日益加剧。因此，成功的药物治疗开发现在不仅包括推进安全有效的新技术，还包括考虑护理、定价和报销的总成本。颠覆性创新是节省成本的新技术，或者通过改善结果和/或降低成本为医疗保健服务增加价值。成功开发颠覆性的肌肉骨骼创新需要平衡临床洞察力、技术知识、供应链管理和商业市场情报。拟议的活动涉及大量的工程和生物工程多学科合作。商业教师的参与提供了一个坚实的方法来最大限度地提高创新疗法的价值的工程系统的挑战。拟议的中心将代表医疗经济学，生物医学科学和临床医学的令人兴奋和新颖的整合，因为我们的目标是降低成本和提高质量的干预措施，用于肌肉骨骼疾病患者的管理。拟建的中心将专注于多学科研究活动的自然整合，从而为在支持的研究活动期间接受指导的学员提供丰富的教育经验。该中心计划实施一项积极的方案，以确定和包括来自代表性不足群体的中心成员和受训人员。重要数据和研究结果将通过中心网站和中心支持的研究成果出版物传播和分享。